Periostin and mesothelin: Potential predictors of malignant progression in intrahepatic cholangiocarcinoma.

about

Periostin and mesothelin: Potential predictors of malignant progression in intrahepatic cholangiocarcinoma.

Item

http://www.wikidata.org/entity/Q55080462

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Periostin and mesothelin: Pote ...... trahepatic cholangiocarcinoma.

@en

Periostin and mesothelin: Pote ...... trahepatic cholangiocarcinoma.

@nl

type

Item

label

Periostin and mesothelin: Pote ...... trahepatic cholangiocarcinoma.

@en

Periostin and mesothelin: Pote ...... trahepatic cholangiocarcinoma.

@nl

prefLabel

Periostin and mesothelin: Pote ...... trahepatic cholangiocarcinoma.

@en

Periostin and mesothelin: Pote ...... trahepatic cholangiocarcinoma.

@nl

P1476

Periostin and mesothelin: Pote ...... trahepatic cholangiocarcinoma.

@en

P2093

Pranoti Mandrekar

http://www.w3.org/2001/XMLSchema#string

Vincenzo Cardinale

http://www.w3.org/2001/XMLSchema#string

P2860

Periostin in intrahepatic cholangiocarcinoma: pathobiological insights and clinical implications.

The role of mesothelin in tumor progression and targeted therapy.

Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.

Emerging molecular therapeutic targets for cholangiocarcinoma.

Recent Advances in Understanding Cholangiocarcinoma.

Periostin promotes malignant potential by induction of epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma.

Overexpression of periostin and distinct mesothelin forms predict malignant progression in a rat cholangiocarcinoma model.

P304

481-483

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1002/HEP4.1189

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29761164

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

5944583

http://www.w3.org/2001/XMLSchema#string